HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The use of intraaortic balloon counterpulsation as an adjunct to reperfusion therapy in cardiogenic shock.

Abstract
Modern coronary care unit interventions have not reduced the high mortality rate associated with cardiogenic shock due to acute myocardial infarction. Results with thrombolytic therapy have also been disappointing because of poor infarct artery patency rates in a low coronary flow state. Percutaneous transluminal coronary angioplasty appears to be a beneficial intervention, but the technique is not available at most hospitals. Intraaortic balloon counterpulsation provides temporary hemodynamic and clinical improvement in the majority of patients with cardiogenic shock. The use of intraaortic counterpulsation to augment patency rates with thrombolytic therapy or to stabilize patients for transfer to a hospital with angioplasty services appears to be a promising strategy for hospitals without an interventional cardiac catheterization laboratory.
AuthorsE R Bates, R J Stomel, J S Hochman, E M Ohman
JournalInternational journal of cardiology (Int J Cardiol) Vol. 65 Suppl 1 Pg. S37-42 (May 29 1998) ISSN: 0167-5273 [Print] Netherlands
PMID9706825 (Publication Type: Journal Article, Review)
Topics
  • Clinical Trials as Topic
  • Hemodynamics
  • Humans
  • Intra-Aortic Balloon Pumping
  • Myocardial Infarction (complications, drug therapy, physiopathology)
  • Shock, Cardiogenic (etiology, mortality, physiopathology, therapy)
  • Survival Analysis
  • Thrombolytic Therapy
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: